Gujrat Kidney & Super Speciality IPO: GMP, Price, Analysis, And Details

Gujarat Kidney & Super Speciality IPO - Company Analysis

Gujarat Kidney & Super Speciality IPO, a Mainboard IPO, is a bookbuilding issue of Rs. 250.80 Cr by Gujarat Kidney & Super Speciality Ltd., and focuses on offering numerous sites in Gujarat, India, multispecialty healthcare services, including secondary and tertiary care.

With a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds, the corporation runs four pharmacies and seven multispecialty hospitals.

Internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynecology, respiratory failure, non-interventional cardiology, diabetology, and anesthesiology are among the medical specialties offered by Gujarat Superspeciality Hospital.

Services:

• Secondary Care Services

• Tertiary Care Services.
  
  

Gujarat Kidney & Super Speciality IPO Details

The Gujarat Kidney & Super Speciality Ltd IPO open date is from Dec 22 to Dec 24, with IPO allotment on Dec 26, refund initiation on Dec 29, 2025.

The Rs. 250.80 Cr mainline IPO comprises a wholly fresh issue of 2.20 crore shares.

The Gujarat Kidney & Super Speciality IPO listing date might be on Tuesday, 30 December 2025, and it will be listed at the BSE and NSE. The Gujarat Kidney & Super Speciality IPO price band is Rs. 108 to Rs. 114 for each Share. 

Events	Date
IPO Opening Date	December 22, 2025
IPO Closing Date	December 24, 2025
IPO Allotment Date	December 26, 2025 (Tentative)
Refund Initiation	December 29, 2025 (Tentative)
Tentative IPO Listing Date	December 30, 2025

 

Industry Outlook

If you want to apply for the IPO, click to open a Demat Account.

 

 

Company Financial

(Amount in Cr)

Period Ended	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	55.34	20.53	3.87
Total Income	40.40	5.48	0.00
PAT	9.50	1.71	-0.01
EBITDA	16.55	1.95	-0.01
Net Worth	25.71	10.80	0.37
Reserves & Surplus	14.57	10.60	0.17
Total Borrowing	3.88	1.94	-

 

Cash Flows

The cash flows for various activities are shown below:

(Amount in Lac)

Net Cash Flow In Multiple Activities	30 Jun 25	FY25	FY24
Net Cash Flow Operating Activities	-44.35	38.73	86.76
Net Cash Flow Investing Activities	-1.83	-159.28	-11.13
Net Cash Flow Financing Activities	21.55	141.40	-46.67

 

Revenue Bifurcation 

(Source RHP)

The Objective of The Issue

• Proposed acquisition of Parekhs Hospital at Ahmedabad. ~ Rs. 77 Cr.

• Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. ~ Rs. 12.40 Cr.

• Funding of the Company's capital expenditure requirements for setting up a new hospital in Vadodara. ~ Rs. 30.10 Cr.

• Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. ~ Rs. 6.83 Cr.

• Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company. ~ Rs. 1.20 Cr.

• Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.

• Acquisition of additional shareholding in the subsidiary, namely “Harmony Medicare Private Limited” at Bharuch. ~ Rs. 10.78 Cr.

Click to check the IPO application status.

Listed Peers of Gujarat Kidney & Super Speciality Ltd.

Company Name	Face Value (₹)	EPS (₹)	P/E (x)
Yatharth Hospital & Trauma Care Services Ltd	10	14.72	55.84
G P Healthcare Ltd	10	6.08	24.51
KMC Speciality Hospitals (India) Ltd	1	1.31	52.60

 

Valuation

KPI	Values
ROE	36.61%
ROCE	37.65%
Debt / Equity	0.15
RoNW	36.61%
PAT Margin	23.61%
EBITDA Margin	41.12%

 

 

Evaluation of P/E Ratio

The company's IPO price of Rs. 114 corresponds to a P/E multiple of 39.44x based on FY25 EPS of Rs. 2.89.

Explore the KSH International IPO.

IPO's Strengths

• Dominance in the renal sciences, with recognized sub-specialties in urology.

• Asset-light business strategy with an emphasis on Gujarat's core region.

• Capacity to draw in and keep qualified, experienced medical professionals.

• Operational and financial performance and growth history.

 

IPO Weaknesses

• Acquisition-based growth may put a burden on management's capacity for execution and bandwidth.

• When demand is poor, operating leverage can exacerbate the negative.

• Revenues and patient trust can be directly impacted by operational problems.

 

Gujarat Kidney & Super Speciality IPO GMP

Gujarat Kidney & Super Speciality IPO GMP today has not started yet as of 16 Dec 2025.

Gujarat Kidney & Super Speciality Limited IPO Summary

IPO Opening & Closing Date	Dec 22, 2025 to Dec 24, 2025
Face Value	Rs. 2 per Share
Issue Price	Rs. 108 to Rs. 114
Lot Size	128 Shares
Issue Size	2,20,00,000 Shares (Rs. 250.80 Cr)
Offer for Sale	-
Fresh Issue	2,20,00,000 Shares (Rs. 250.80 Cr)
Listing At	BSE, NSE
Issue Type	Book Built Issue IPO
Registrar	MUFG Intime India Pvt. Ltd.

 

Gujarat Kidney & Super Speciality IPO Lot Size

The Gujarat Kidney & Super Speciality Ltd. IPO allows retail investors to invest in a minimum and maximum of 1 Lot (128 Shares) amounting to Rs. 14592 and 13 Lots (1664 Shares) amounting to Rs. 189696, respectively, while for S-HNI investors, the minimum Lot is 14 (1792 Shares) amounting to Rs. 204288.

Minimum Lot Investment (Retail)	1 Lot
Maximum Lot Investment (Retail)	13 Lots
SHNI (Minimum)	14 Lots
SHNI (Maximum)	68 Lots
BHNI (Minimum)	69 Lots

 

Gujarat Kidney & Super Speciality IPO Reservation

Institutional Share Portion	75%
Retail Investors' Share Portion	10%
Non-Institutional Shares Portion	15%

 

Gujarat Kidney & Super Speciality IPO Allotment Status

To check the Gujarat Kidney & Super Speciality IPO allotment status, visit the official Registrar’s website or the BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

 

Promoters And Management of Gujarat Kidney & Super Speciality  Ltd.

• Dr. Pragnesh Yashwantsinh Bharpoda

• Dr. Bhartiben Pragnesh Bharpoda

• Dr. Yashwantsingh Motisinh Bharpoda

• Anitaben Yashwantsinh Bharpoda. 

Pre-Issue Promoter Shareholding	99.10%
Post-Issue Promoter Shareholding	71.45%

 

Gujarat Kidney & Super Speciality IPO Lead Managers

• Nirbhay Capital Services Pvt. Ltd. 

 

Dividend Policy

The company has not paid a dividend during the past three financial years.

 

 

Conclusion

Exposure to a rapidly expanding multispecialty hospital chain with a focus on Gujarat and good profitability measures including high ROE and EBITDA margins is provided by the Gujarat Kidney & Super Speciality IPO. The IPO price, which appears reasonable when compared to public rivals, is supported by expansion plans and an acquisition-led growth strategy. 

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.